EP News Bureau

ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company  

It is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton…

The Life Sciences Sector Skill Development Council (LSSSDC) in collaboration with Pharmacy Council of India (PCI) has announced…

MuDiTa has been transporting vaccines for major pharma companies like Serum Institute, Sanofi India, Sun Pharma, Wockhardt,…

Caplin Steriles, a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and…

SpiceJet has signed a Memorandum of Understanding (MoU) with GMR Hyderabad Air Cargo (GHAC), the cargo division of GMR Air Cargo…

Aurobindo Pharma said that it would make and sell US-based COVAXX’s COVID-19 vaccine candidate for supply in India and to the…

The Gujarat Government gives Rs 200 Crore to support early-stage student innovators and start ups to develop their POC and venture…

we hypothesize that BBV152 can generate antibodies that may persist for 6-12 months.

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris…